Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126024731 | 12602473 | 1 | I | 20160608 | 0 | 20160727 | 20160727 | DIR | 63.00 | YR | F | N | 0.00000 | 20160610 | N | PH | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126024731 | 12602473 | 1 | PS | INSULIN GLARGINE | INSULIN GLARGINE | 1 | Subcutaneous | N | Y | 0 | 10 | IU | HS | ||||||
| 126024731 | 12602473 | 3 | C | AMPICILLIN/SULBACTAM | AMPICILLIN SODIUMSULBACTAM SODIUM | 1 | 0 | ||||||||||||
| 126024731 | 12602473 | 5 | C | DEXTROSE. | DEXTROSE | 1 | 0 | ||||||||||||
| 126024731 | 12602473 | 7 | C | HEPARIN | HEPARIN SODIUM | 1 | 0 | ||||||||||||
| 126024731 | 12602473 | 9 | C | METHADONE | METHADONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126024731 | 12602473 | 11 | C | ZINC OXIDE. | ZINC OXIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126024731 | 12602473 | 1 | Hyperglycaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126024731 | 12602473 | Hypoglycaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126024731 | 12602473 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126024731 | 12602473 | 1 | 20160607 | 0 |